Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels

Human Genetics

Volumn 112, Issue 5-6, 2003, Pages 610-616

  Damcott, Coleen M ^a,b   Feingold, Eleanor ^b   Moffett, Susan P ^b   Barmada, M Michael ^b   Marshall, Julie A ^c   Hamman, Richard F ^c   Ferrell, Robert E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FAT; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; GENE PRODUCT; LUCIFERASE; PROTEIN PGL3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARRIER PROTEIN; FABP2 PROTEIN, MOUSE; LIPID; TUMOR PROTEIN;

ARTICLE; BODY COMPOSITION; BODY MASS; CELL STRAIN CACO 2; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DNA VECTOR; ENZYME ASSAY; ETHNIC DIFFERENCE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION;

INSERTION SEQUENCES;

ANALYSIS OF VARIANCE; BODY COMPOSITION; CARRIER PROTEINS; FATTY ACID-BINDING PROTEINS; LIPIDS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0038281191     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-0937-1     Document Type: Article

References (31)

1. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M (1998) Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid binding protein 2 gene. Arterioscler Thromb Vasc Biol 18:1606-1610
2. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287
3. Baier LJ, Bogardus C, Sacchettini JC (1996) A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271:10892-10896
4. Bernlohr DA, Simpson MA, Vogel Hertzel A, Banaszak LJ (1997) Intracellular lipid-binding proteins and their genes. Annu Rev Nutr 17:277-303
5. Chiu KC, Chuang LM, Yoon C (2001) Fatty acid binding protein 2 and insulin resistance. Eur J Clin Invest 31:521-527
6. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-322
7. Galluzzi JR, Cupples LA, Meigs JB, Wilson PWF, Schaefer EJ, Ordovas JM (2001a) Association of the ala54-thr polymorphism in the intestinal fatty acid binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care 24:1161-1166
8. Galluzzi JR, Cupples LA, Otvos JD, Wilson PWF, Schaefer EJ, Ordovas JM (2001b) Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis 159:417-424
9. Georgopoulos A, Aras O, Tsai MY (2000) Codon-54 polymorphism of the fatty acid binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85:3155-3160
10. Glatz JFC, Storch J (2001) Unravelling the significance of cellular fatty acid-binding proteins. Curr Opin Lipidol 12:267-274
11. Glatz JFC, Vork MM, Cistola DP, Van Der Vusse GJ (1993) Cytoplasmic fatty acid binding protein: Significance for intracellular transport of fatty acids and putative role in signal transduction pathways. Prostaglandins Leukot Essent Fatty Acids 48:33-41
12. Glatz JFC, Borchers T, Spener F, Van Der Vusse GJ (1995) Fatty acids in cell signalling: Modulation by lipid binding proteins. Prostaglandins Leukot Essent Fatty Acids 52:121-127
13. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC (1989) Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: The San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311
14. Hegele RA, Harris SB, Hanley AJG, Sadikian S, Connelly PW, Zinman B (1996) Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81:4334-4337
15. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK (2001) Transcriptional coregulators of the nuclear receptor superfamily: Coactivators and corepressors. Cell Mol Life Sci 58:289-297
16. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL (1999) Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: The Atherosclerosis Risk in Communities Study. Diabetes 48:1868-1872
17. Marshall JA, Grunwald GK, Donahoo WT, Scarbro S, Shetterly SM (2000) Percent body fat and lean mass explain the gender difference in leptin: Analysis and interpretation of leptin in Hispanic and non-Hispanic white adults. Obesity Res 8:543-552
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
19. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW (1999) Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12
20. Mochizuki K, Suruga K, Sakaguchi N, Takase S, Goda T (2002) Major intestinal coactivator p300 strongly activates peroxisome proliferator-activated receptor in intestinal cell line, Caco-2. Gene 291:271-277
21. Pihlajamäki J, Rissanen J, Heikkinen S, Karjalainen L, Laakso M (1997) Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17:1039-1044
22. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, Bennett PH, Bogardus C (1993) Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 42:514-519
23. Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356
24. Sparkes RS, Mohandas T, Heinzmann C, Gordon JI, Klisak I, Zollman S, Sweetser DA, Ragunathan L, Winokur S, Lusis AJ (1987) Human fatty acid binding protein assignments intestinal to 4q28-4q31 and liver to 2p11. Cytogenet Cell Genet 46:697
25. Stavropoulos WS, Crouch RD (1974) A new caloric procedure for the determination of serum triglycerides (abstract). Clin Chem 20:857
26. Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T, Lusis AJ, Gordon JI (1987) The human and rodent intestinal fatty acid binding protein genes: A comparative analysis of their structure, expression, and linkage relationships. J Biol Chem 262:16060-16071
27. Takahashi N, Kawada T, Yamamoto T, Goto T, Taimatsu A, Aoki N, Kawasaki H, Taira K, Yokoyama KK, Kamei Y, Fushiki T (2002) Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J Biol Chem 277:16906-16912
28. Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, Masana L, Ehnholm C (2000) Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 152:317-325
29. Vassileva G, Huwyler L, Poirier K, Agellon LB, Toth MJ (2000) The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 14:2040-2046
30. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pruss M, Reuter I, Schacherer F (2000) TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 28:316-319
31. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, Koyama W, Nonaka K (1997) Association between ala54thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40:706-710